Back to Trades
Total Value
$110.5K
Net $110.5K sold
Filing Date
Jul 24, 2026
1 transaction
Sales
$110.5K
1 transaction
Trade Summary
On Jul 23, 2026, Stout Jay S, Chief Technology Officer, sold $110.5K of Immunovant, Inc. (IMVT) across 1 transaction. The filing covers Common Stock and reflects net selling of $110.5K. Reported prices ranged from $38.69. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Immunovant, Inc.
- Ticker Symbol
- IMVT
- CIK
- 0001764013
Insider Information
- Name
- Stout Jay S
- Role
- Chief Technology Officer
- Location
- DURHAM, NC
Filing Details
- Filing Date
- Jul 24, 2026
- Transaction Date
- Jul 23, 2026
- Accession Number
- 0001702969-26-000010
- Form Type
- 4
- Net Trading Amount
- -$110.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 23, 2026 | Common Stock | 2,857 | $38.69 | Sale | $110.5K |
Want live alerts when Stout Jay S trades again?
Download Insider Trades to track IMVT, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on July 17, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- (F2)The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.18 - $39.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.